Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease
By O. El-Agnaf, Sultan A. Salem, K. Paleologou, M. Curran, Mark J. Gibson, J. Court, M. Schlossmacher, D. Allsop. The FASEB Journal, 2006
751 citations recorded by the source corpus.
Subfields: Cellular and Molecular Neuroscience, Neurology
View Paper: https://www.semanticscholar.org/paper/508e2bdb60161e8123124623ddd502abebbeaded
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cellular and Molecular Neuroscience
In Neurology
Citations in the corpus
- Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival (2010, background): “The concentration of secreted -synuclein was estimated to be 2–12 nM, which resembles the levels so far detected in biological fluids (data not shown) (Borghi et al., 2000; El-Agnaf et al., 2003, 2006).”
- DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. (2010, neutral): “In addition, El-Agnaf et al. (2006) have shown a significant”
- Exosomal cell-to-cell transmission of alpha synuclein oligomers (2012, background): “The main component of Lewy bodies and Lewy neurites are fibrillar aggregates of αsyn [1] but a growing body of evidence suggests that prefibrillar oligomers of αsyn are key contributors in the progression of Parkinson's disease [9-15].”